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Abstract
Wilson’s disease is a rare genetic disorder of copper metabolism that causes primary hepatic
cirrhosis, secondary menstrual abnormalities and infertility. Following the appropriate therapy
patients are asymptomatic and pregnancy may be achieved. We present a case of placental abruption
in a pregnant woman with Wilson’s disease and we review the management dilemmas and treatment
options of pregnant women with Wilson’s disease.
Introduction
Wilson’s disease is an inherited autosomal recessive
disorder of copper metabolism caused by defective copper
transporting ATPase in the liver. Because of impaired
biliary secretion, copper remains in the liver, resulting in
chronic hepatitis, hepatic cirrhosis and central nervous
system dysfunction [1]. Wilson’s disease is a rare disorder
with a worldwide prevalence of 1:30.000 [2]. Presentation
is more common in the early twenties. With appropriate
chelating therapy patients are expected to be asympto-
matic, when therapy begins very early or when patients are
diagnosed in an asymptomatic stage of the disease. Prior
to introduction of proper medical treatment, successful
pregnancies were rare due to reduced fertility (menstrual
irregularities and early onset of chronic liver disease) [3].
However, when early diagnosis is made and proper
therapy is administrated, pregnancy can be achieved.
Case report
A 28-year old Caucasian woman (gravida 1, para 0) was
referred to our outpatient antenatal clinic at the 6
th week
of her pregnancy for her booking appointment. She had
been trying to conceive for the previous 4 years. She
reported that she was suffering from Wilson’s disease since
puberty and she had been on penicillamine 1 g/day for
more than 10 years. At the time she got pregnant she was
completely asymptomatic.
Proper counseling was offered concerning all the possible
implications of her pregnancy and the need of continua-
tion of her chelating medical treatment. A low dose
regimen of penicillamine 500 mg/day was commenced,
according to the hepatologist advice. She attended all the
routine antenatal appointments regularly. All her blood
tests were within normal range, particularly those
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prescribed during the first trimester in a daily dose of
400 μg, while no iron supplementation was needed
throughout her pregnancy. The fetal nuchal translucency
was measured 1,1 mm at 12 weeks of pregnancy, while the
fetal anomaly scan at 22 weeks showed no obvious
abnormality. Another two scans were performed antena-
tally in 28 and 32 weeks of gestation, in order to check the
fetal growth and well-being.
She was admitted at 37 weeks in the labour ward with
antepartum haemorrhage and constant abdominal pain,
which started 1 hour prior to her admission. An
ultrasound scan was performed and a large retroplacental
haematoma was detected suggestive of placenta abrup-
tion. An emergency uncomplicated caesarean section was
performed and a male infant weighed 2870 g was
delivered. The ultrasound finding of placenta abruption
was confirmed intraoperatively. The fetal APGARscore was
8 and 9 at the 1
st and 5
th minute respectively and did not
need any kind of resuscitation. Her post-operative course
was uneventful and she was discharged home with her
baby on the 4
th postoperative day. Her postnatal obstetric
and medical appointments revealed no obvious patho-
logy. Shortly postnatally her hepatologist recommenced
her with 1 gr/day of penicillamine as before pregnancy.
Discussion
Wilson’s disease is a genetic disorder in which there is
excessive accumulation of copper in the liver and brain
because of an inherited defect in its biliary excretion [4]. It
is transmitted from generation to generation by autosomal
recessive inheritance. Homozygote of the specific muta-
tions of both alleles of the Wilson’s disease gene or doubly
heterozygous for different gene mutations may manifest
the full clinical course of the disease [1].
Responsible for the transport of copper from the
hepatocytes to bile is the protein ATP7B. The Wilson’s
disease gene mutation leads to absence or diminished
function of ATP7B, resulting in a decrease in biliary copper
excretion [5].
The copper excess accumulates progressively in the liver
causing toxic changes. When the capacity of the liver is
exceeded, copper diffuses into the blood stream and
distributes to other organs, mainly the brain, kidneys and
eyes [1]. Clinical manifestations are rare before adoles-
cence, but eventually develop in all untreated patients by
early twenties [6]. Presentation varies depending on the
organ mostly affected by the abnormal copper accumula-
tion, and can be with hepatic dysfunction when liver is
affected and neurologic disturbances and Kayser - Fleischer
rings in the cornea when copper deposition in the brain or
eyes is excessive.
There are two major issues in the reproductive profile of
women with Wilson’s disease: infertility due to menstrual
irregularities and recurrent miscarriages at the first
trimester. The former is the result of hormonal changes
caused by hepatic failure and copper toxicity [3] and the
later is caused probably because of increased copper
deposition in the uterus [7].
These two factors, including chronic liver disease, endo-
crinal disorders and anaemias, can explain why there are
only few case reports in the literature about successful
pregnancies in women with Wilson’s disease. Despite
these facts it seems that patients who receive proper
treatment may be able to conceive and reach a favorable
outcome of pregnancy [1,4,8].
Currently there is four drugs used as anticopper agents in
non-pregnant women: penicillamine, zinc, trientine and
tetrathiomolybdate [1]. They all show about the same
effectiveness, but their usage during pregnancy is always a
matter of debate in relation to possible teratogenicity.
Penicillamine is the most widely used medication. Since
the first documentation of its effectiveness [9], penicilla-
mine has been regularly used to keep pregnant women
asymptomatic. The dosage of 500 mg/day proves to be
almost harmless to the fetus and quite effective at the same
time for the treatment of the disease [5,7,8], although the
dosage depends basically on the individual data of the
patient and the stage of the copper-intoxication. Despite
these studies, proper counseling should always be offered
to pregnant women and their families regarding birth
defects caused by penicillamine in larger doses, such as
cutis laxa like syndrome, micrognathia, low-set ears,
hyperflexibility of joints, fragile veins, varicosity and
impaired wound healing [10]. Close monitoring of
women throughout their pregnancies is crucial in order
to prevent early symptoms of the disease due to
inadequate therapy and to check their compliance with
treatment.
Zinc isthesecond mostused regiment for Wilson’sdisease.
Although the evidence is scant, the existing literature
suggests that it is equally harmless and effective to
penicillamine for the treatment of pregnant women [11].
Unfortunately there are no data in the literature concern-
ing the usage of the other two agents during pregnancy.
The optimal mode of delivery varies according to the
physical status of the pregnant woman. In healthy
asymptomatic women vaginal delivery should be the
first choice, while caesarean section should be reserved for
emergencies or when other pathology is present. In our
case placental abruption was the indication for performing
a caesarean section. It should also be noted that to the best
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placenta abruption in a pregnant woman with Wilson’s
disease. We believe that copper deposition in uterus may
has caused the abruption of the placenta, since we could
not detect any of the known causes or predisposing factors
for placenta abruption. We must also state that this
hypothesis is only suggestive, as there are no data of the
level of copper in the woman’s blood at the time of
ceasarean section or placental histology.
Conclusion
It is clear that the reproductive status of women with
Wilson’s disease is quite problematic. With proper medical
treatment and close monitoring before and during
pregnancy, a successful outcome can be achieved.
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